tetano
Editor, Senior Moderator
Infect Dis Model
. 2022 Mar 11.
doi: 10.1016/j.idm.2022.02.003. Online ahead of print.
Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models
Mohammad Mihrab Chowdhury[SUP] 1 [/SUP], Md Rafiul Islam[SUP] 2 [/SUP], Md Sakhawat Hossain[SUP] 1 [/SUP], Nusrat Tabassum[SUP] 1 [/SUP], Angela Peace[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus Disease (COVID-19), which began as a small outbreak in Wuhan, China in December 2019, became a global pandemic within months due to its high transmissibility. In the absence of pharmaceutical treatment, various non-pharmaceutical interventions (NPIs) to contain the spread of COVID-19 brought the entire world to a halt. After almost a year of seemingly returning to normalcy with the world's quickest vaccine development, the emergence of more infectious and vaccine resistant coronavirus variants is bringing the situation back to where it was a year ago. In the light of this new situation, we conducted a study to portray the possible scenarios based on the three key factors: impact of interventions (pharmaceutical and NPIs), vaccination rate, and vaccine efficacy. In our study, we assessed two of the most crucial factors, transmissibility and vaccination rate, in order to reduce the spreading of COVID-19 in a simple but effective manner. In order to incorporate the time-varying mutational landscape of COVID-19 variants, we estimated a weighted transmissibility composed of the proportion of existing strains that naturally vary over time. Additionally, we consider time varying vaccination rates based on the number of daily new cases. Our method for calculating the vaccination rate from past active cases is an effective approach in forecasting probable future scenarios as it actively tracks people's attitudes toward immunization as active cases change. Our simulations show that if a large number of individuals cannot be vaccinated by ensuring high efficacy in a short period of time, adopting NPIs is the best approach to manage disease transmission with the emergence of new vaccine breakthrough and more infectious variants.
Keywords: Break-through variants; Non-pharmaceutical interventions (NPIs); Reinfection; Vaccination rate; Waning immunity.
. 2022 Mar 11.
doi: 10.1016/j.idm.2022.02.003. Online ahead of print.
Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models
Mohammad Mihrab Chowdhury[SUP] 1 [/SUP], Md Rafiul Islam[SUP] 2 [/SUP], Md Sakhawat Hossain[SUP] 1 [/SUP], Nusrat Tabassum[SUP] 1 [/SUP], Angela Peace[SUP] 1 [/SUP]
Affiliations
- PMID: 35291223
- PMCID: PMC8913432
- DOI: 10.1016/j.idm.2022.02.003
Abstract
Coronavirus Disease (COVID-19), which began as a small outbreak in Wuhan, China in December 2019, became a global pandemic within months due to its high transmissibility. In the absence of pharmaceutical treatment, various non-pharmaceutical interventions (NPIs) to contain the spread of COVID-19 brought the entire world to a halt. After almost a year of seemingly returning to normalcy with the world's quickest vaccine development, the emergence of more infectious and vaccine resistant coronavirus variants is bringing the situation back to where it was a year ago. In the light of this new situation, we conducted a study to portray the possible scenarios based on the three key factors: impact of interventions (pharmaceutical and NPIs), vaccination rate, and vaccine efficacy. In our study, we assessed two of the most crucial factors, transmissibility and vaccination rate, in order to reduce the spreading of COVID-19 in a simple but effective manner. In order to incorporate the time-varying mutational landscape of COVID-19 variants, we estimated a weighted transmissibility composed of the proportion of existing strains that naturally vary over time. Additionally, we consider time varying vaccination rates based on the number of daily new cases. Our method for calculating the vaccination rate from past active cases is an effective approach in forecasting probable future scenarios as it actively tracks people's attitudes toward immunization as active cases change. Our simulations show that if a large number of individuals cannot be vaccinated by ensuring high efficacy in a short period of time, adopting NPIs is the best approach to manage disease transmission with the emergence of new vaccine breakthrough and more infectious variants.
Keywords: Break-through variants; Non-pharmaceutical interventions (NPIs); Reinfection; Vaccination rate; Waning immunity.